Opinion|Videos|June 5, 2024
An Overview of Potential Treatment Adverse Effects
An expert on chronic lymphocytic leukemia discusses adverse effects encountered by patients who are receiving BTK inhibitors or venetoclax-based regimens.
Advertisement
Episodes in this series
Video content above is prompted by the following question(s):
- What types of adverse effects may patients encounter with BTK inhibitor therapy? Venetoclax?
- How are these adverse effects typically managed and how does a multidisciplinary team contribute to this process?
- What guidance do you offer to patients to assist them in effective management of potential adverse events?
Advertisement
Related Content
Advertisement
Advertisement
Trending on CURE
1
FDA Grants Breakthrough Status to Enhertu for Some HER2+ Early Breast Cancers
2
What Palliative Care Means for Patients with Metastatic Breast Cancer
3
How Nutrition Impacts Breast Cancer Risk and Recovery
4
Orserdu Combo Shows Potential for ER+/HER2– Breast Cancer
5